PathologyWatch is a company that specializes in improving pathology through artificial intelligence on top of modernized software tools. The company is led by Dan Lambert, a successful serial entrepreneur and graduate of Harvard Business School, and Greg Osmond, a Dermatopathologist trained at Harvard Medical School. The Salt Lake-based company sells to Dermatologists who are looking to digitize their workflows and leverage our AI tools to improve skin cancer diagnostics. The company is venture-backed by leading firms and has raised ~$40M. The team is dedicated to fighting skin cancer globally, bringing skin cancer diagnostics to underserved areas in the US and abroad. PathologyWatch is currently a team of ~50 people and growing quickly.